Idarucizumab for Urgent Reversal of Dabigatran for Heart Transplant: A Case Report

American Journal of Hematology - United States
doi 10.1002/ajh.24638
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Idarucizumab for the Reversal of Dabigatran in Patients Undergoing Heart Transplantation

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Successful Intravenous Thrombolysis for Ischemic Stroke After Reversal of Dabigatran Anticoagulation With Idarucizumab: A Case Report

Journal of Medical Case Reports
Medicine
2017English

Idarucizumab Resistance Due to a Markedly Elevated Dabigatran Concentration – A Case Report

Pathology
Forensic MedicinePathology
2020English

Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study

Cardiology and Therapy
2020English

Adverse Clinical Outcomes After Dabigatran Reversal With Idarucizumab to Facilitate Acute Stroke Thrombolysis

Journal of Neurology
Neurology
2017English

Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke

Frontiers in Neurology
Neurology
2019English

Therapeutic Plasma Exchange for Urgent Rivaroxaban Reversal

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2018English

Mechanical Circulatory Support as Bridge Therapy for Heart Transplant: Case Series Report

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2018English

First Reported Case of Hemopericardium Related to Dabigatran Use Reversed by New Antidote Idarucizumab

Case Reports in Cardiology
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy